Search research articles
Contact Us
Filters
Showing results (11-20 of 44) with videos related to
Page
of 5
Sort By:
Molecular Cancer Therapeutics
|
June 19, 2007
Breast cancer cells with acquired antiestrogen resistance are sensitized to cisplatin-induced cell death
Christina Westmose Yde, Mads Gyrd-Hansen, Anne E Lykkesfeldt, et al.
European Journal of Medicinal Chemistry
|
February 18, 2021
Design of pyrido[2,3-d]pyrimidin-7-one inhibitors of receptor interacting protein kinase-2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling
Sameer Nikhar, Ioannis Siokas, Lisa Schlicher, et al.
Cancer Research
|
August 4, 2004
Sensitization to the lysosomal cell death pathway upon immortalization and transformation
Nicole Fehrenbacher, Mads Gyrd-Hansen, Birgit Poulsen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 2, 2021
Tryptophanemia is controlled by a tryptophan-sensing mechanism ubiquitinating tryptophan 2,3-dioxygenase
Simon Klaessens, Vincent Stroobant, Delia Hoffmann, et al.
The Journal of Experimental Medicine
|
August 18, 2004
Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization
Jesper Nylandsted, Mads Gyrd-Hansen, Agnieszka Danielewicz, et al.
FEBS Letters
|
August 19, 2007
Heregulin-induced epigenetic regulation of the utrophin-A promoter
Utpal Basu, Mads Gyrd-Hansen, Santhosh M Baby, et al.
Molecular and Cellular Biology
|
September 13, 2006
Apoptosome-independent activation of the lysosomal cell death pathway by caspase-9
Mads Gyrd-Hansen, Thomas Farkas, Nicole Fehrenbacher, et al.
Molecular Cell
|
June 29, 2013
OTULIN restricts Met1-linked ubiquitination to control innate immune signaling
Berthe Katrine Fiil, Rune Busk Damgaard, Sebastian Alexander Wagner, et al.
Molecular Cell
|
April 15, 2014
Molecular basis and regulation of OTULIN-LUBAC interaction
Paul R Elliott, Sofie V Nielsen, Paola Marco-Casanova, et al.
EMBO Molecular Medicine
|
July 3, 2013
Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling
Rune Busk Damgaard, Berthe Katrine Fiil, Carsten Speckmann, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 44) with videos related to
Sort By:
Page
of 5
Molecular Cancer Therapeutics
|
June 19, 2007
Breast cancer cells with acquired antiestrogen resistance are sensitized to cisplatin-induced cell death
Christina Westmose Yde, Mads Gyrd-Hansen, Anne E Lykkesfeldt, et al.
European Journal of Medicinal Chemistry
|
February 18, 2021
Design of pyrido[2,3-d]pyrimidin-7-one inhibitors of receptor interacting protein kinase-2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling
Sameer Nikhar, Ioannis Siokas, Lisa Schlicher, et al.
Cancer Research
|
August 4, 2004
Sensitization to the lysosomal cell death pathway upon immortalization and transformation
Nicole Fehrenbacher, Mads Gyrd-Hansen, Birgit Poulsen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 2, 2021
Tryptophanemia is controlled by a tryptophan-sensing mechanism ubiquitinating tryptophan 2,3-dioxygenase
Simon Klaessens, Vincent Stroobant, Delia Hoffmann, et al.
The Journal of Experimental Medicine
|
August 18, 2004
Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization
Jesper Nylandsted, Mads Gyrd-Hansen, Agnieszka Danielewicz, et al.
FEBS Letters
|
August 19, 2007
Heregulin-induced epigenetic regulation of the utrophin-A promoter
Utpal Basu, Mads Gyrd-Hansen, Santhosh M Baby, et al.
Molecular and Cellular Biology
|
September 13, 2006
Apoptosome-independent activation of the lysosomal cell death pathway by caspase-9
Mads Gyrd-Hansen, Thomas Farkas, Nicole Fehrenbacher, et al.
Molecular Cell
|
June 29, 2013
OTULIN restricts Met1-linked ubiquitination to control innate immune signaling
Berthe Katrine Fiil, Rune Busk Damgaard, Sebastian Alexander Wagner, et al.
Molecular Cell
|
April 15, 2014
Molecular basis and regulation of OTULIN-LUBAC interaction
Paul R Elliott, Sofie V Nielsen, Paola Marco-Casanova, et al.
EMBO Molecular Medicine
|
July 3, 2013
Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling
Rune Busk Damgaard, Berthe Katrine Fiil, Carsten Speckmann, et al.
Page
of 5